Aptagen, LLC is a biotechnology and life-sciences company. We are a global leader in developing ‘synthetic antibodies’ called aptamers, with over 25 years of experience. Aptamers are target-recognition elements with high affinity and specificity against targets such as small molecules, protein biomarkers, cells, and tissues. Aptamers are an alternative platform to that of antibodies for diagnostic, therapeutic, and bio-industrial applications.
Dr G Thomas Caltagirone
President & CEO, AptaGen LLC, 250 North Main Street, Jacobus, PA 17407, USA